St. Elizabeth Healthcare Partners with CTI and Pulmotect Becoming First Hospital Site for Phase-2 Clinical Trial Targeting COVID-19 Edgewood, KY— St. Elizabeth Healthcare has been selected as the first site of the FDA-approved Phase- 2 COVID-19 clinical trial studying the drug PUL-042 of Pulmotect, Inc., in partnership with CTI Clinical Trial and Consulting Services (CTI), […]
